Comparison of the efficacy and safety of amisulpride versus low-dose amisulpride plus low-dose sulpiride in treatment of schizophrenia

Trial Profile

Comparison of the efficacy and safety of amisulpride versus low-dose amisulpride plus low-dose sulpiride in treatment of schizophrenia

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 17 Jun 2013

At a glance

  • Drugs Amisulpride (Primary) ; Sulpiride (Primary)
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 06 Jun 2012 New source identified and integrated: ClinicalTrials.gov record NCT01615185.
    • 07 Sep 2011 Results presented at the 24th Annual Congress of the European College of Neuropsychopharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top